(Q30977303)

11 November 2017

Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine (English)

1 reference

11 November 2017

Marina Caskey

21

0 references

Josephine H Cox

26

object named as

Josephine Cox

1 reference

11 November 2017

Sandhya Vasan

1

1 reference

11 November 2017

Sarah J Schlesinger

2

1 reference

11 November 2017

Zhiwei Chen

3

1 reference

11 November 2017

Arlene Hurley

4

1 reference

11 November 2017

Angela Lombardo

5

1 reference

11 November 2017

Soe Than

6

1 reference

11 November 2017

Phumla Adesanya

7

1 reference

11 November 2017

Catherine Bunce

8

1 reference

11 November 2017

Mark Boaz

9

1 reference

11 November 2017

Rosanne Boyle

10

1 reference

11 November 2017

Eddy Sayeed

11

1 reference

11 November 2017

Lorna Clark

12

1 reference

11 November 2017

Daniel Dugin

13

1 reference

11 November 2017

Mar Boente-Carrera

14

1 reference

11 November 2017

Claudia Schmidt

15

1 reference

11 November 2017

Qing Fang

16

1 reference

11 November 2017

LeiBa

17

1 reference

11 November 2017

Yaoxing Huang

18

1 reference

11 November 2017

Gerasimos J Zaharatos

19

1 reference

11 November 2017

David F Gardiner

20

1 reference

11 November 2017

Laura Seamons

22

1 reference

11 November 2017

Martin Ho

23

1 reference

11 November 2017

Len Dally

24

1 reference

11 November 2017

Carol Smith

25

1 reference

11 November 2017

Dilbinder Gill

27

1 reference

11 November 2017

Jill Gilmour

28

1 reference

11 November 2017

Michael C Keefer

29

1 reference

11 November 2017

Patricia Fast

30

1 reference

11 November 2017

David D Ho

31

1 reference

11 November 2017

language of work or name

English

0 references

publication date

25 January 2010

1 reference

11 November 2017

1 reference

11 November 2017

5

1 reference

11 November 2017

1

1 reference

11 November 2017

e8816

1 reference

Creative Commons Attribution 4.0 International

11 November 2017

start time

25 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Vaccine protection by live, attenuated simian immunodeficiency virus in the absence of high-titer antibody responses and high-frequency cellular immune responses measurable in the periphery

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Design, construction, and characterization of a dual-promoter multigenic DNA vaccine directed against an HIV-1 subtype C/B' recombinant.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Design, construction, and characterization of a multigenic modified vaccinia Ankara candidate vaccine against human immunodeficiency virus type 1 subtype C/B'.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

HIV incidence, retention, and changes of high-risk behaviors among rural injection drug users in Guangxi, China

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Expansion of HIV/AIDS in China: lessons from Yunnan Province

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag c

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Adverse events associated with smallpox vaccination in the United States, January-October 2003.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2810329

Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003

25 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20111599

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20111599

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Development of an HIV-1 reference panel of subtype B envelope clones isolated from the plasma of recently infected individuals

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20111599

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0008816

1 reference

11 November 2017

0 references

1 reference

11 November 2017

PubMed publication ID

20111599

1 reference